Immediate Impact
2 from Science/Nature 54 standout
Citing Papers
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
2024 Standout
Works of June Warden being referenced
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| June Warden | 280 | 290 | 7 | 116 | 6 | 401 | |
| Tanja Rixecker | 230 | 309 | 149 | 5 | 416 | ||
| A Pagnoni | 148 | 223 | 51 | 7 | 369 | ||
| O. Lindén | 143 | 189 | 87 | 13 | 424 | ||
| Indra Thielen | 197 | 210 | 2 | 43 | 9 | 420 | |
| Dan Painter | 174 | 245 | 1 | 122 | 10 | 443 | |
| J E Neely | 229 | 269 | 119 | 10 | 436 | ||
| Imke Strohscheer | 123 | 39 | 1 | 43 | 10 | 412 | |
| Susan S. Devesa | 186 | 137 | 3 | 22 | 8 | 384 | |
| S. Wiedenmann | 180 | 271 | 1 | 89 | 8 | 343 | |
| Karin Ekström‐Smedby | 155 | 196 | 4 | 66 | 6 | 394 |
All Works
Loading papers...